TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Aros Forskning & Friskvård AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
27
|
17
|
24 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
22
|
9
|
15 |
EBITDA |
22
|
9
|
15 |
Total assets |
68
|
53
|
62 |
Current assets |
19
|
10
|
18 |
Current liabilities |
7
|
3
|
5 |
Equity capital |
61
|
49
|
56 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
89.7%
|
92.5%
|
90.3% |
Turnover per employee |
27
|
17
|
24 |
Profit as a percentage of turnover |
81.5%
|
52.9%
|
62.5% |
Return on assets (ROA) |
32.4%
|
17.0%
|
24.2% |
Current ratio |
271.4%
|
333.3%
|
360.0% |
Return on equity (ROE) |
36.1%
|
18.4%
|
26.8% |
Change turnover |
10
|
-5
|
-39 |
Change turnover % |
58%
|
-22%
|
-62% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.